GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regeneron Pharmaceuticals Inc (MIC:REGN-RM) » Definitions » Accounts Payable

Regeneron Pharmaceuticals (MIC:REGN-RM) Accounts Payable : ₽58,288.23 Mil (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Regeneron Pharmaceuticals Accounts Payable?

Regeneron Pharmaceuticals's Accounts Payable for the quarter that ended in Mar. 2025 was ₽58,288.23 Mil.

Regeneron Pharmaceuticals's quarterly Accounts Payable increased from Sep. 2024 (₽45,067.81 Mil) to Dec. 2024 (₽84,950.99 Mil) but then declined from Dec. 2024 (₽84,950.99 Mil) to Mar. 2025 (₽58,288.23 Mil).

Regeneron Pharmaceuticals's annual Accounts Payable increased from Dec. 2022 (₽36,059.04 Mil) to Dec. 2023 (₽54,733.52 Mil) and increased from Dec. 2023 (₽54,733.52 Mil) to Dec. 2024 (₽84,950.99 Mil).


Regeneron Pharmaceuticals Accounts Payable Historical Data

The historical data trend for Regeneron Pharmaceuticals's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regeneron Pharmaceuticals Accounts Payable Chart

Regeneron Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35,435.21 41,699.34 36,059.04 54,733.52 84,950.99

Regeneron Pharmaceuticals Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 61,424.62 50,777.68 45,067.81 84,950.99 58,288.23

Regeneron Pharmaceuticals Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Regeneron Pharmaceuticals Accounts Payable Related Terms

Thank you for viewing the detailed overview of Regeneron Pharmaceuticals's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Regeneron Pharmaceuticals Business Description

Address
777 Old Saw Mill River Road, Tarrytown, NY, USA, 10591-6707
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).

Regeneron Pharmaceuticals Headlines

No Headlines